Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

COMPASS PATHWAYS PLC (CMPS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

COMPASS PATHWAYS PLC (CMPS), most recent 12 months reported: net loss $394.19M. Latest balance sheet on file: liquid cash $433.3M, total debt $50.73M, net cash $382.57M. From SEC filings. Others in Pharmaceutical Preparations: Cingulate Inc. · Cellectar Biosciences, Inc. · CLIMB BIO, INC. · SNOWDRIFT PARENT CORPORATION · CNBX PHARMACEUTICALS INC. · CNS Pharmaceuticals, Inc. · CONTEXT THERAPEUTICS INC. · COCRYSTAL PHARMA, INC.

Stock screener

Watchlist